Google's Verily Stumbles Amid CEO's Questionable Business Approach and Ethics Allegations Post author:Sam Post published:April 11, 2016 Post category:BioPharma April 11, 2016By Mark… Source: BioSpace You Might Also Like Canada's Concordia Accused of 6,000% Price Increase for Drug, Overcharging NHS by 100M Pounds November 21, 2017 IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain February 2, 2017 Taxus Cardium Release: Excellagen Receives Notice Of Allowance For A New Patent Application Covering Blood Platelet Activation & Endogeneous Growth Factor Release For Wound Repair And Tissue Regeneration June 12, 2017
Canada's Concordia Accused of 6,000% Price Increase for Drug, Overcharging NHS by 100M Pounds November 21, 2017
IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain February 2, 2017
Taxus Cardium Release: Excellagen Receives Notice Of Allowance For A New Patent Application Covering Blood Platelet Activation & Endogeneous Growth Factor Release For Wound Repair And Tissue Regeneration June 12, 2017
